Skip to main content
Log in

ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Purpose

Nelson’s syndrome (NS) is regarded as an aggressive complication of total bilateral adrenalectomy (TBA) for Cushing’s disease (CD). This challenge may be addressed by using clinical criteria to guide frequency of neuroimaging to enable timely management of NS and also avoid unnecessary frequent imaging.

Methods

All patients (n = 43) with CD subjected to TBA over 35 years at a tertiary care centre were included. NS was defined as a newly appearing or expanding (> 2 mm) pituitary adenoma with or without ACTH levels exceeding 500 pg/ml. Pre-and post-TBA parameters like clinical symptomatology, cortisol, ACTH and radiology were analysed for the prediction of NS.

Results

NS developed in 39.5% (n = 17) patients with a median follow-up of 7 years. Half of them had new appearance, while rest had an expansion of pre-existing pituitary tumour. Majority (90%) had ACTH above 500 pg/ml. On Cox proportional hazards analysis, frequent discriminatory features of protein catabolism (≥ 4) (HR 1.15, CI 0.18, 7.06), proximal myopathy (HR 8.82, CI 1.12, 69.58) and annual ACTH increment of 113 pg/ml (HR 12.56, CI 1.88, 88.76) predicted NS. First post-operative year ACTH indices predicting NS included ACTH rise of 116 pg/ml and absolute ACTH of 142 pg/ml (sensitivity, specificity exceeding 90%). Annual ACTH increment exceeding 113 pg/ml, ≥ 4 discriminatory features and uncontrolled hypertension had the best overall prediction.

Conclusion

Patients who developed NS had higher rebound rise of ACTH following TBA and a more severe disease phenotype at baseline. Consistent ACTH increment can be used as a marker for predicting the development of NS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NS:

Nelson’s syndrome

CD:

Cushing’s disease

CS:

Cushing’s syndrome

TSS:

Trans-sphenoidal surgery

TBA:

Total bilateral adrenalectomy

ACTH:

Adrenocorticotropic hormone

ONDST:

Overnight dexamethasone suppression test

LDDST:

Low dose dexamethasone suppression test

HDDST:

High dose dexamethasone suppression test

IRMA:

Immunoradiometric assay

ECLIA:

Electrochemiluminescence assay

CV:

Coefficient of variation

IQR:

Interquartile range

SD:

Standard deviation

UFC:

Urinary free cortisol

References

  1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing's syndrome. Lancet 367:1605–1617

    Article  CAS  PubMed  Google Scholar 

  2. Petersenn S, Beckers A, Ferone D, van der Lely AJ, Bollerslev J, Boscaro M et al (2015) Outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol 172(6):R227–R239

    Article  CAS  PubMed  Google Scholar 

  3. Reincke M, Ritzel K, Oßwald A, Berr C, Stalla G, Hallfeldt K, Reisch N, Schopohl J, Beuschlein F (2015) A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome. Eur J Endocrinol 173(4):M23–32

    Article  CAS  PubMed  Google Scholar 

  4. Guerin C, Taieb D, Treglia G, Brue T, Lacroix A, Sebag F, Castinetti F (2016) Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism? Endocr Relat Cancer 23(2):R131–R142

    Article  CAS  PubMed  Google Scholar 

  5. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol 100(8):2807–2831

    Article  CAS  Google Scholar 

  6. Katznelson L (2015) Bilateral adrenalectomy for Cushing’s disease. Pituitary 18:269–273

    Article  CAS  PubMed  Google Scholar 

  7. Chow JT, Thompson GB, Grant CS, Farley DR, Richards ML, Young WF Jr (2008) Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol 68(4):513–519

    Article  Google Scholar 

  8. Ritzel K, Beuschlein F, Mickisch A, Osswald A, Schneider HJ, Schopohl J, Reincke M (2013) Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 98:3939–3948

    Article  CAS  PubMed  Google Scholar 

  9. Nelsons DH, Meakin JW, Dealy JB Jr, Matson DD, Emerson K Jr, Thorn GW (1958) ACTH-producing tumour of the pituitary gland. N Engl J Med 259:161–164

    Article  Google Scholar 

  10. Barber TM, Adams E, Ansorge O, Byrne JV, Karavitaki N, Wass JA (2010) Nelson’s syndrome. Eur J Endocrinol 163:495–507

    Article  CAS  PubMed  Google Scholar 

  11. Assié G, Bahurel H, Coste J, Silvera S, Kujas M, Dugué MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X (2007) Corticotroph tumour progression after adrenalectomy in Cushing’s disease: a reappraisal of Nelson’s syndrome. J Clin Endocrinol Metab 92:172–179

    Article  CAS  PubMed  Google Scholar 

  12. Fountas A, Lim ES, Drake WM, Powlson AS, Gurnell M, Martin NM, Seejore K, Murray RD, MacFarlane J, Ahluwalia R, Swords F (2019) Outcomes of patients with Nelson’s syndrome after primary treatment: a multicenter study from 13 UK Pituitary centers. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgz200

    Article  Google Scholar 

  13. Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing's disease. World J Surg 24:108–113

    Article  CAS  PubMed  Google Scholar 

  14. Baranetsky NG, Zipser RD, Goebelsmann U, Robert RJ, March CM, Morimoto I, Stanczyk FZ (1979) Adrenocorticotropin-dependent virilizing paraovarian tumours in Nelson’s syndrome. J Clin Endocrinol Metab 49:381–386

    Article  CAS  PubMed  Google Scholar 

  15. Verdonk C, Guerin C, Lufkin E, Hodgson SF (1982) Activation of virilizing adrenal rest tissues by excessive ACTH production: an unusual presentation of Nelson’s syndrome. Am J Med 73:455–459

    Article  CAS  PubMed  Google Scholar 

  16. Carlstrom LP, Graffeo CS, Perry A, Stokken JK, Van Gompel JJ (2019) Nelson-Salassa syndrome progressing to pituitary carcinoma: a case report and review of the literature. Cureus 11(9):5595

    Google Scholar 

  17. Graffeo CS, Perry A, Carlstrom LP, Meyer FB, Atkinson JL, Erickson D, Nippoldt TB, Young WF, Pollock BE, Van Gompel JJ (2017) Characterizing and predicting the Nelson-Salassa syndrome. J Neurosurg 127:1277–1287

    Article  CAS  PubMed  Google Scholar 

  18. Kemink L, Pieters GF, Hermus AR, Smals A, Kloppenborg P (1994) Patient's age is a simple predictive factor for the development of Nelson’s syndrome after total adrenalectomy for Cushing's disease. J Clin Endocrinol Metab 79:887–889

    PubMed  CAS  Google Scholar 

  19. Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB, Stewart PM (2001) Expression of 11β-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumours. J Clin Endocrinol Metab 86:2728–2733

    PubMed  CAS  Google Scholar 

  20. Ar W, Odell Wd (1980) The dose-response relationship of ACTH and cortisol in Cushing's disease. Clin Endocrinol (Oxford) 12:557–568

    Article  Google Scholar 

  21. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. The Lancet 366:1059–1062

    Article  Google Scholar 

  22. Misra A (2015) Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement. Diabet Technol Ther 17:667–671

    Article  Google Scholar 

  23. American Diabetes Association (2020) Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care 43(Supplement 1):S14–31

    Article  Google Scholar 

  24. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ (2017ACC) 2017ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71(19):e127–248

    Article  PubMed  Google Scholar 

  25. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DS, Mechanick JI, Pessah-Pollack R (2017) American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract 23(s2):1–87

    Article  PubMed  Google Scholar 

  26. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Verschraegen I, Anckaert E, Schiettecatte J, Mees M, Garrido A, Hermsen D et al (2007) Multicenter evaluation of a rapid electrochemiluminescent adrenocorticotropic hormone (ACTH) immunoassay. Clin Chim Acta 380:75–80

    Article  CAS  PubMed  Google Scholar 

  28. Raff H, Findling JW (1989) A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 35:596–600

    Article  CAS  PubMed  Google Scholar 

  29. Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of Cushing's disease. Endocr Rev 36(4):385–486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Munir A, Newell-Price J (2007) Nelson's syndrome. Arquivos Brasileiros de Endocrinologia & Metabologia 51:1392–1396

    Article  Google Scholar 

  31. Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785

    PubMed  CAS  Google Scholar 

  32. Espinosa-de-Los-Monteros AL, Sosa-Eroza E, Espinosa E, Mendoza V, Arreola R, Mercado M (2017) Long-term outcome of the different treatment alternatives for recurrent and persistent Cushing disease. Endocr Pract 23:759–767

    Article  PubMed  Google Scholar 

  33. Pereira MA, Halpern A, Salgado LR, Mendonça BB, Nery M, Liberman B, Streeten DH, Wajchenberg BL (1998) A study of patients with Nelson’s syndrome. Clin Endocr (Oxford) 49:533–539

    Article  CAS  Google Scholar 

  34. Sonino NI, Zielezny MA, Fava GA, Fallo F, Boscaro M (1996) Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 81:2647–2652

    PubMed  CAS  Google Scholar 

  35. Palermo NE, Ananthakrishnan S (2015) Re-examining Nelson's syndrome. Curr Opin Endocrinol Diabetes Obes 22(4):313–318

    Article  CAS  PubMed  Google Scholar 

  36. Assié G, Bahurel H, Bertherat J, Kujas M, Legmann P, Bertagna X (2004) The Nelson's syndrome revisited. Pituitary 7:209–215

    Article  PubMed  Google Scholar 

  37. Pérez-Rivas LG, Theodoropoulou M, Puar TH, Fazel J, Stieg MR, Ferraù F, Assié G, Gadelha MR, Deutschbein T, Fragoso MC, Kusters B (2018) Somatic USP8 mutations are frequent events in corticotroph tumour progression causing Nelson’s tumour. Eur J Endocrinol 178:57–63

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are highly indebted to late Prof Kanchan Kumar Mukherjee, who was instrumental in providing neurosurgical expertise as part of the treating team catering to these patients of Cushing’s disease at our centre. Unfortunately, he is no more with us but his legacy continues to live on.

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Contributions

LD did data compilation and analysis, drafted the manuscript, edited it and reviewed the literature. AB edited the manuscript and supervised patient management. RP was involved in interpretation of data and editing the manuscript. PD edited the manuscript and supervised patient management. SKB supervised patient management. CA provided neuro-radiological expertise in terms of imaging interpretation and/or inferior petrosal sinus sampling. SK, RM and ARB did adrenal surgery. UNS performed histopathological analysis. SSD did pituitary surgery. RW conceived the study, managed the patients, collected the data, performed interpretation of data and statistical analysis and edited the manuscript.

Corresponding author

Correspondence to Rama Walia.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

Institutional ethics committee approval was obtained.

Consent to participate

Written informed consent for enrollment was obtained from participants or their relatives as applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Das, L., Bhansali, A., Pivonello, R. et al. ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome. Pituitary 23, 488–497 (2020). https://doi.org/10.1007/s11102-020-01047-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-020-01047-x

Keywords

Navigation